Monthly Archives: March 2023

The Chancellor has announced his Spring Budget today, including within it two VAT changes related to community pharmacy services, which PSNC had been pressing for over several years and was a focus within our CPCF negotiations. From 1st May 2023, Government will extend the VAT exemption on healthcare to include medical services carried out by [...]

The post Budget brings VAT changes but no wider relief for community pharmacy appeared first on PSNC Website.

Elections for the non-CCA Multiple Representatives and Regional Representatives started on 9th March. Voting contractors were sent an email to either the head office contact or premises shared NHSmail address detailing who is standing for election and a unique link to the voting portal. We are asking contractors to make their vote as soon as [...]

The post PSNC Elections – Just over a week left to make your vote appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has announced that that the following product will have a redetermination due to late notification of a price increase, this will apply from December 2022 to February 2023: Mebeverine 50mg/5ml oral suspension sugar free (300ml) – £205.70 (instead of £187.00) Pharmacy contractors should note that this is [...]

The post Redetermination for Mebeverine 50mg/5ml oral suspension sugar free appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (15/03/2023) granted the following initial list of price concessions for March 2023. Drug Pack size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 125mg/5ml oral suspension 100 £4.32 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.80 [...]

The post March 2023 Price Concessions 1st Update appeared first on PSNC Website.

Drug alert number: EL (23)A/09 Date issued: 14 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Pholcodine-containing products (Various Marketing Authorisation Holders) Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the [...]

The post MHRA Class 2 Medicines Recall: Pholcodine-containing products (Various Marketing Authorisation Holders) appeared first on PSNC Website.